• 1
    Rajakumar, K., S. L. Greenspan, S. B. Thomas and M. F. Holick (2007) SOLAR ultraviolet radiation and vitamin D: A historical perspective. Am. J. Public Health 97, 17461754.
  • 2
    Bischoff-Ferrari, H. A., W. C. Willett, J. B. Wong, E. Giovannucci, T. Dietrich and B. Dawson-Hughes (2005) Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 293, 22572264.
  • 3
    Garland, C. F., F. C. Garland, E. D. Gorham, M. Lipkin, H. Newmark, S. B. Mohr and M. F. Holick (2006) The role of vitamin D in cancer prevention. Am. J. Public Health 96, 252261.
  • 4
    Giovannucci, E., Y. Liu, E. B. Rimm, B. W. Hollis, C. S. Fuchs, M. J. Stampfer and W. H. Willett (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl Cancer Inst. 98, 451459.
  • 5
    Grant, W. B. and C. F. Garland (2006) The association of solar ultraviolet B (UVB) with reducing risk of cancer: Multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res. 26, 26872699.
  • 6
    Lappe, J. M., D. Travers-Gustafson, K. M. Davies, R. R. Recker and R. P. Heaney (2007) Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am. J. Clin. Nutr. 85, 15861591.
  • 7
    Holick, M. F. (2005) Vitamin D: Important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South. Med. J. 98, 10241027.
  • 8
    Peterlik, M. and H. S. Cross (2006) Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases. Anticancer Res. 26, 25812588.
  • 9
    Mullin, G. E. and A. Dobs (2007) Vitamin D and its role in cancer and immunity: A prescription for sunlight. Nutr. Clin. Pract. 22, 305322.
  • 10
    Grant, W. B. (2007) Roles of solar ultraviolet radiation and vitamin D in human health and how to obtain vitamin D. Expert Rev. Dermatol. 2, 563577.
  • 11
    Autier, P. and S. Gandini (2007) Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch. Intern. Med. 167, 17301737.
  • 12
    Roelandts, R. (2002) The history of phototherapy: Something new under the sun? J. Am. Acad. Dermatol. 46, 926930.
  • 13
    Liu, P. T., S. Stenger, D. H. Tang and R. L. Modlin (2007) Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 179, 20602063.
  • 14
    Zanetti, M. (2004) Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 3948.
  • 15
    Golec, M. (2007) Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Ann. Agric. Environ. Med. 14, 14.
  • 16
    Sadeghi, K., B. Wessner, U. Laggner, M. Ploder, D. Tamandl, J. Friedl, U. Zugel, A. Steinmeyer, A. Pollak, E. Roth, G. Boltz-Nitulescu and A. Spittler (2006) Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 36, 361370.
  • 17
    Cannell, J. J., R. Vieth, J. C. Umhau, M. F. Holick, W. B. Grant, S. Madronich, C. F. Garland and E. Giovannucci (2006) Epidemic influenza and vitamin D. Epidemiol. Infect. 134, 11291140.
  • 18
    Ganz, T. (2003) Defensins: Antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710720.
  • 19
    Aloia, J. F. and M. Li-Ng (2007) Re: epidemic influenza and vitamin D. Epidemiol. Infect. 135, 10951096; author reply 1097–1098.
  • 20
    Yusuf, S., G. Piedimonte, A. Auais, G. Demmler, S. Krishnan, P. Van Caeseele, R. Singleton, S. Broor, S. Parveen, L. Avendano, J. Parra, S. Chavez-Bueno, D. E. Murguia, T. Sierra, E. A. Simoes, S. Shaha and R. Welliver (2007) The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol. Infect. 135, 10771090.
  • 21
    Gombart, A. F., Q. T. Luong and H. P. Koeffler (2006) Vitamin D compounds: Activity against microbes and cancer. Anticancer Res. 26, 25312542.
  • 22
    Wang, T. T., F. P. Nestel, V. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L. Tavera-Mendoza, R. Lin, J. W. Hanrahan, S. Mader and J. H. White (2004) Cutting edge: 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173, 29092912.
  • 23
    Gombart, A. F., N. Borregaard and H. P. Koeffler (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19, 10671077.
  • 24
    Gombart, A. F., J. O’Kelly, T. Saito and H. P. Koeffler (2007) Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues. J. Steroid Biochem. Mol. Biol. 103(3-5), 552557.
  • 25
    Brot, C., N. R. Jorgensen and O. H. Sorensen (1999) The influence of smoking on vitamin D status and calcium metabolism. Eur. J. Clin. Nutr. 53, 920926.
  • 26
    Murin, S. and K. S. Bilello (2005) Respiratory tract infections: Another reason not to smoke. Cleve. Clin. J. Med. 72, 916920.
  • 27
    Norval, M., J. Garssen, H. Van Loveren and A. A. El-Ghorr (1999) UV-induced changes in the immune response to microbial infections in human subjects and animal models. J. Epidemiol. 9(6 Suppl.), S84S92.
  • 28
    Hrushesky, W. J., R. B. Sothern, W. J. Rietveld, J. Du-Quiton and M. E. Boon (2006) Sun exposure, sexual behavior and uterine cervical human papilloma virus. Int. J. Biometeorol. 50, 167173.
  • 29
    Norval, M. (2006) The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog. Biophys. Mol. Biol. 92, 108118.
  • 30
    Hale, A., K. Mattick, D. Lewis, M. Estes, X. Jiang, J. Green, R. Eglin and D. Brown (2000) Distinct epidemiological patterns of Norwalk-like virus infection. J. Med. Virol. 62, 99103.
  • 31
    Putzker, M., H. Sauer, G. Kirchner, O. Keksel and A. Malic (2000) Community acquired diarrhea—The incidence of Astrovirus infections in Germany. Clin. Lab. 46, 269273.
  • 32
    Suzuki, H., T. Sakai, N. Tanabe and N. Okabe (2005) Peak rotavirus activity shifted from winter to early spring in Japan. Pediatr. Infect. Dis. J. 24, 257260.
  • 33
    Canals, M. (1997) Seasonal patterns of infectious disease: Similarity and differences. Rev. Med. Chil. 125, 403408 (Spanish).
  • 34
    Hope-Simpson, R. E. (1981) The role of season in the epidemiology of influenza. J. Hyg. 86, 3547.
  • 35
    Laube, D. M., S. Yim, L. K. Ryan, K. O. Kisich and G. Diamond (2006) Antimicrobial peptides in the airway. Curr. Top. Microbiol. Immunol. 306, 153182.
  • 36
    Howell, M. D., A. Wollenberg, R. L. Gallo, M. Flaig, J. E. Streib, C. Wong, T. Pavicic, M. Boguniewicz and D. Y. Leung (2006) Cathelicidin deficiency predisposes to eczema herpeticum. J. Allergy Clin. Immunol. 117, 836841.
  • 37
    Bergman, P., L. Walter-Jallow, K. Broliden, B. Agerberth and J. Soderlund (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr. HIV Res. 5, 410415.
  • 38
    Auwaerter, P. G. (2006) Recent advances in the understanding of infectious mononucleosis: Are prospects improved for treatment or control? Expert Rev. Anti Infect. Ther. 4, 10391049.
  • 39
    Douglas, A. S., T. Brown and D. Reid (1996) Infectious mononucleosis and Hodgkin’s disease—A similar seasonality. Leuk. Lymphoma 23(3-4), 323331.
  • 40
    Beadling, C. and M. K. Slifka (2004) How do viral infections predispose patients to bacterial infections? Curr. Opin. Infect. Dis. 17, 185191.
  • 41
    Danai, P. A., M. Moss, D. M. Mannino and G. S. Martin (2006) The epidemiology of sepsis in patients with malignancy. Chest 129, 14321440.
  • 42
    Mookherjee, N., L. M. Rehaume and R. E. Hancock (2007) Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 11, 9931004.
  • 43
    Colizza, V., A. Barrat, M. Barthelemy, A. J. Valleron and A. Vespignani (2007) Modeling the worldwide spread of pandemic influenza: Baseline case and containment interventions. PLoS Med. 4, e13.
  • 44
    Cox, M. M. (2007) Vaccines in development against avian influenza. Minerva Med. 98, 145153.
  • 45
    Lewis, E. N., M. R. Griffin, P. G. Szilagyi, Y. Zhu, K. M. Edwards and K. A. Poehling (2007) Childhood influenza: Number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics 120, 467472.
  • 46
    Monto, A. S. (1997) Prospects for pandemic influenza control with currently available vaccines and antivirals. J. Infect. Dis. 176(Suppl. 1), S32S37.
  • 47
    Davidson, A. and B. Diamond (2001) Autoimmune diseases. N. Engl. J. Med. 345, 340350.
  • 48
    Geier, D. A. and M. R. Geier (2005) A case–control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38, 295301.
  • 49
    Davenport, C. B. (1922) Multiple sclerosis from the standpoint of geographic distribution and race. Proc. Assoc. Res. Nerv. Ment. Dis. 2, 819.
  • 50
    Wallin, M. T., W. F. Page and J. F. Kurtzke (2004) Multiple sclerosis in US veterans of the Vietnam era and later military service: Race, sex, and geography. Ann. Neurol. 55, 6571.
  • 51
    Goldberg, P. (1974) Multiple sclerosis: Vitamin D and calcium as environmental determinants of prevalence. Part 1: Sunlight, dietary factors and epidemiology. Int. J. Environ. Stud. 6, 1927.
  • 52
    Hayes, C. E., M. T. Cantorna and H. F. DeLuca (1997) Vitamin D and multiple sclerosis. Proc. Soc. Exp. Biol. Med. 216, 2127.
  • 53
    Van Der Mei, I. A., A. L. Ponsonby, L. Blizzard and T. Dwyer (2001) Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 20, 168174.
  • 54
    Ascherio, A. and K. L. Munger (2007) Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann. Neurol. 61, 288299.
  • 55
    Holmoy, T. (2007) Vitamin D status modulates the immune response to Epstein–Barr virus: Synergistic effect of risk factors in multiple sclerosis. Med. Hypotheses (Epub ahead of print).
  • 56
    Ruprecht, K. (2007) Multiple sclerosis and Epstein–Barr virus: New developments and perspectives. Nervenarzt (Epub ahead of print) (in German).
  • 57
    Falkenbach, A. and A. Sedlmeyer (1997) Travel to sunny countries is associated with changes in immunological parameters. Photodermatol. Photoimmunol. Photomed. 13, 139142.
  • 58
    Van Der Mei, I. A., A. L. Ponsonby, T. Dwyer, L. Blizzard, R. Simmons, B. V. Taylor, H. Butzkueven and T. Kilpatrick (2003) Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case–control study. BMJ 327, 316.
  • 59
    Islam, T., W. J. Gauderman, W. Cozen and T. M. Mack (2007) Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 69, 381388.
  • 60
    Leffell, D. J. and D. E. Brash (1996) Sunlight and skin cancer. Sci. Am. 275, 5253. Available at : Accessed on 30 September 2007.
  • 61
    Grant, W. B. and M. F. Holick (2005) Benefits and requirements of vitamin D for optimal health: A review. Altern. Med. Rev. 10, 94111.
  • 62
    McKinney, P. A., R. Parslow, K. A. Gurney, G. R. Law, H. J. Bodansky and R. Williams (1999) Perinatal and neonatal determinants of childhood type 1 diabetes. A case–control study in Yorkshire, UK. Diabetes Care 22, 928932.
  • 63
    Tenconi, M. T., G. Devoti, M. Comelli, M. Pinon, A. Capocchiano, V. Calcaterra and G. Pretti; Pavia T1DM Registry Group (2007) Major childhood infectious diseases and other determinants associated with type 1 diabetes: A case–control study. Acta Diabetol. 44, 1419.
  • 64
    Hypponen, E., E. Laara, A. Reunanen, M. R. Jarvelin and S. M. Virtanen (2001) Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 358, 15001503.
  • 65
    Littorin, B., P. Blom, A. Scholin, H. J. Arnqvist, G. Blohme, J. Bolinder, A. Ekbom-Schnell, J. W. Eriksson, S. Gudbjornsdottir, L. Nystrom, J. Ostman and G. Sundkvist (2006) Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: Results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 49, 28472852.
  • 66
    Hanson, L. A. (2007) Session 1: Feeding and infant development. Breast-feeding and immune function. Proc. Nutr. Soc. 66, 384396.
  • 67
    Staples, J. A., A. L. Ponsonby, L. L. Lim and A. J. McMichael (2003) Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: Latitude, regional ultraviolet radiation, and disease prevalence. Environ. Health Perspect. 111, 518523.
  • 68
    Lora-Gomez, R. E., F. M. Morales-Perez, F. J. Arroyo-Diez and J. Barquero-Romero (2005) Incidence of Type 1 diabetes in children in Caceres, Spain, during 1988–1999. Diabetes Res. Clin. Pract. 69, 169174.
  • 69
    Busse, W. W., J. E. Gern and E. C. Dick (1997) The role of respiratory viruses in asthma. Ciba Found. Symp. 206, 208213.
  • 70
    Ponsonby, A. L., T. Dwyer, I. Van Der Mei, A. Kemp, L. Blizzard, B. Taylor, T. Kilpatrick and R. Simmons (2006) Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life. Clin. Exp. Immunol. 146, 463470.
  • 71
    Proud, D. and C. W. Chow (2006) Role of viral infections in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 35, 513518.
  • 72
    Douville, R. N., N. Bastien, Y. Li, F. E. Simons and K. T. HayGlass (2007) Adult asthmatics display exaggerated IFNgamma responses to human metapneumovirus and respiratory syncytial virus. Biochem. Cell Biol. 85, 252258.
  • 73
    Piippo-Savolainen, E., M. Korppi, K. Korhonen and S. Remes (2007) Adult asthma after non-respiratory syncytial virus bronchiolitis in infancy: Subgroup analysis of the 20-year prospective follow-up study. Pediatr. Int. 49, 190195.
  • 74
    Traves, S. L. and D. Proud (2007) Viral-associated exacerbations of asthma and COPD. Curr. Opin. Pharmacol. 7, 252258.
  • 75
    Camargo, C. A., Jr, S. L. Rifas-Shiman, A. A. Litonjua, J. W. Rich-Edwards, S. T. Weiss, D. R. Gold, K. Kleinman and M. W. Gillman (2007) Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am. J. Clin. Nutr. 85, 788795.
  • 76
    Devereux, G., A. A. Litonjua, S. W. Turner, L. C. Craig, G. McNeill, S. Martindale, P. J. Helms, A. Seaton and S. T. Weiss (2007) Maternal vitamin D intake during pregnancy and early childhood wheezing. Am. J. Clin. Nutr. 85, 853859.
  • 77
    Hypponen, E., U. Sovio, M. Wjst, S. Patel, J. Pekkanen, A. L. Hartikainen and M. R. Jarvelinb (2004) Infant vitamin D supplementation and allergic conditions in adulthood: Northern Finland birth cohort 1966. Ann. N. Y. Acad. Sci. 1037, 8495.
  • 78
    Garcia-Marcos, L., I. Carvajal Uruena, A. Escribano Montaner, M. Fernandez Benitez, S. Garcia de la Rubia, E. Tauler Toro, V. Perez Fernandez and C. Barcina Sanchez (2007) Seasons and other factors affecting the quality of life of asthmatic children. J. Investig. Allergol. Clin. Immunol. 17, 249256.
  • 79
    Thomson, N. C. (2007) The role of environmental tobacco smoke in the origins and progression of asthma. Curr. Allergy Asthma Rep. 7, 303309.
  • 80
    Gilmour, M. I., M. S. Jaakkola, S. J. London, A. E. Nel and C. A. Rogers (2006) How exposure to environmental tobacco smoke, outdoor air pollutants, and increased pollen burdens influences the incidence of asthma. Environ. Health Perspect. 114, 627633.
  • 81
    Mallia, P. and S. L. Johnston (2006) How viral infections cause exacerbation of airway diseases. Chest 130, 12031210.
  • 82
    Soilu-Hanninen, M., L. Airas, I. Mononen, A. Heikkila, M. Viljanen and A. Hanninen (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult. Scler. 11, 266271.
  • 83
    Cantorna, M. T. (2006) Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 92, 6064.
  • 84
    Ascherio, A. and K. L. Munger (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann. Neurol. 61, 504513.
  • 85
    Resch, A., U. Schlipkoter, A. Crispin, H. Behrendt, J. Heinrich, H. E. Wichmann, J. Ring and T. Schafer; The KORA study group (2004) Atopic disease and its determinants—A focus on the potential role of childhood infection. Clin. Exp. Allergy 34, 11841191.
  • 86
    Weiland, S. K., A. Husing, D. P. Strachan, P. Rzehak and N. Pearce; ISAAC Phase One Study Group (2004) Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup. Environ. Med. 61, 609615.
  • 87
    Kramer, U., S. Weidinger, U. Darsow, M. Mohrenschlager, J. Ring and H. Behrendt (2005) Seasonality in symptom severity influenced by temperature or grass pollen: Results of a panel study in children with eczema. J. Invest. Dermatol. 124, 514523.
  • 88
    Edwards, C. J. and C. Cooper (2006) Early environmental factors and rheumatoid arthritis. Clin. Exp. Immunol. 143, 15.
  • 89
    Cutolo, M., K. Otsa, K. Laas, M. Yprus, R. Lehtme, M. E. Secchi, A. Sulli, S. Paolino and B. Seriolo (2006) Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin. Exp. Rheumatol. 24, 702704.
  • 90
    Merlino, L. A., J. Curtis, T. R. Mikuls, J. R. Cerhan, L. A. Criswell and K. G. Saag; Iowa Women’s Health Study (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women’s Health Study. Arthritis Rheum. 50, 7277.
  • 91
    Patel, S., T. Farragher, J. Berry, D. Bunn, A. Silman and D. Symmons (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 56, 21432149.
  • 92
    Varoga, D., T. Pufe, R. Mentlein, S. Kohrs, S. Grohmann, B. Tillmann, J. Hassenpflug and F. Paulsen (2005) Expression and regulation of antimicrobial peptides in articular joints. Ann. Anat. 187(5–6), 499508.
  • 93
    Harley, J. B. and J. A. James (2006) Epstein–Barr virus infection induces lupus autoimmunity. Bull. NYU Hosp. Jt Dis. 64, 4550.
  • 94
    Harley, J. B., I. T. Harley, J. M. Guthridge and J. A. James (2006) The curiously suspicious: A role for Epstein–Barr virus in lupus. Lupus 15, 768777.
  • 95
    Edwards, C. J. and C. Cooper (2006) Early environmental exposure and the development of lupus. Lupus 15, 814819.
  • 96
    Montgomery, S. M., D. L. Morris, R. E. Pounder and A. J. Wakefield (1999) Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 116, 796803.
  • 97
    Xavier, R. J. and D. K. Podolsky (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427434.
  • 98
    Sonnenberg, A., D. J. McCarty and S. J. Jacobsen (1991) Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 100, 143149.
  • 99
    Sonnenberg, A. and I. H. Wasserman (1991) Epidemiology of inflammatory bowel disease among U.S. military veterans. Gastroenterology 101, 122130.
  • 100
    Sonnenberg, A. (2007) Similar geographic variations in mortality from peptic ulcer and inflammatory bowel disease. Inflamm. Bowel Dis. 13, 763768.
  • 101
    Lewis, J. D., F. N. Aberra, G. R. Lichtenstein, W. B. Bilker, C. Brensinger and B. L. Strom (2004) Seasonal variation in flares of inflammatory bowel disease. Gastroenterology 126, 665673.
  • 102
    Aratari, A., C. Papi, B. Galletti, E. Angelucci, A. Viscido, V. D’Ovidio, A. Ciaco, M. Abdullahi and R. Caprilli (2006) Seasonal variations in onset of symptoms in Crohn’s disease. Dig. Liver Dis. 38, 319323.
  • 103
    Froicu, M., V. Weaver, T. A. Wynn, M. A. McDowell, J. E. Welsh and M. T. Cantorna (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17, 23862392.
  • 104
    Froicu, M. and M. T. Cantorna (2007) Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 8, 5.
  • 105
    Pappa, H. M., C. M. Gordon, T. M. Saslowsky, A. Zholudev, B. Horr, M. C. Shih and R. J. Grand (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118, 19501961.
  • 106
    Boscoe, F. P. and M. J. Schymura (2006) Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer 6, 264.
  • 107
    John, E. M., J. Koo and G. G. Schwartz (2007) Sun exposure and prostate cancer risk: Evidence for a protective effect of early-life exposure. Cancer Epidemiol. Biomarkers Prev. 16, 12831286.
  • 108
    Freedman, D. M., A. C. Looker, S. C. Chang and B. I. Graubard (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl Cancer Inst. 99, 15941602.
  • 109
    Van Den Bemd, G. J. and G. T. Chang (2002) Vitamin D and vitamin D analogs in cancer treatment. Curr. Drug Targets 3, 8594.
  • 110
    Lamprecht, S. A. and M. Lipkin (2003) Chemoprevention of colon cancer by calcium, vitamin D and folate: Molecular mechanisms. Nat. Rev. Cancer 3, 601614.
  • 111
    Tuohimaa, P., L. Tenkanen, M. Ahonen, S. Lumme, E. Jellum, G. Hallmans, P. Stattin, S. Harvei, T. Hakulinen, T. Luostarinen, J. Dillner, M. Lehtinen and M. Hakama (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case–control study in the Nordic countries. Int. J. Cancer 108, 104108.
  • 112
    Stolzenberg-Solomon, R. Z., R. Vieth, A. Azad, P. Pietinen, P. R. Taylor, J. Virtamo and D. Albanes (2006) A prospective nested case–control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res. 66, 1021310219.
  • 113
    Chen, W., S. M. Dawsey, Y. L. Qiao, S. D. Mark, Z. W. Dong, P. R. Taylor, P. Zhao and C. C. Abnet (2007) Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br. J. Cancer 97, 123128.
  • 114
    Kinoshita, S., Y. Wagatsuma and M. Okada (2007) Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan. Int. J. Health Geogr. 6, 34.
  • 115
    Skinner, H. G., D. S. Michaud, E. Giovannucci, W. C. Willett, G. A. Colditz and C. S. Fuchs (2006) Vitamin D intake and the risk of pancreatic cancer in two cohort studies. Cancer Epidemiol. Biomarkers Prev. 15, 16881695.
  • 116
    Shuyama, K., A. Castillo, F. Aguayo, Q. Sun, N. Khan, C. Koriyama and S. Akiba (2007) Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br. J. Cancer 96, 15541559.
  • 117
    Chan, J. M., E. Giovannucci, S. O. Andersson, J. Yuen, H. O. Adami and A. Wolk (1998) Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control 9, 559566.
  • 118
    Chan, J. M., F. Wang and E. A. Holly (2007) Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California. Cancer Causes Control 18, 11531167.
  • 119
    Zhou, W., R. S. Heist, G. Liu, K. Asomaning, D. S. Neuberg, B. W. Hollis, J. C. Wain, T. J. Lynch, E. Giovannucci, L. Su and D. C. Christiani (2007) Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J. Clin. Oncol. 25, 479485.
  • 120
    Porojnicu, A., T. E. Robsahm, J. P. Berg and J. Moan (2007) Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: A possible role of sun-induced vitamin D. J. Steroid Biochem. Mol. Biol. 103, 675678.
  • 121
    Grant, W. B. (2007) A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: Additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J. Steroid. Biochem. Mol. Biol. 103, 668674.
  • 122
    Grant, W. B. (2007) An ecologic study of cancer mortality rates in Spain with respect to indices of solar UV irradiance and smoking. Int. J. Cancer 120, 11231127.
  • 123
    Tuohimaa, P., E. Pukkala, G. Scelo, J. H. Olsen, D. H. Brewster, K. Hemminki, E. Tracey, E. Weiderpass, E. V. Kliewer, V. Pompe-Kirn, M. L. McBride, C. Martos, K. S. Chia, J. M. Tonita, J. G. Jonasson, P. Boffetta and P. Brennan (2007) Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: Vitamin D as a possible explanation. Eur. J. Cancer 43, 17011712.
  • 124
    Grant, W. B. (2007) The effect of solar UVB doses and vitamin D production, skin cancer action spectra, and smoking in explaining links between skin cancers and solid tumours. Eur. J. Cancer (Epub ahead of print).
  • 125
    De Vries, E., I. Soerjomataram, S. Houterman, M. W. Louwman and J. W. Coebergh (2007) Decreased risk of prostate cancer after skin cancer diagnosis: A protective role of ultraviolet radiation? Am. J. Epidemiol. 165, 966972.
  • 126
    Armstrong, B. and R. Doll (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer 15, 617631.
  • 127
    Doll, R. and R. Peto (1981) The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst. 66, 11911308.
  • 128
    DiMaio, D. and L. B. Liao (2006) Human papillomaviruses and cervical cancer. Adv. Virus Res. 66, 125159.
  • 129
    Hjalgrim, H., K. E. Smedby, K. Rostgaard, D. Molin, S. Hamilton-Dutoit, E. T. Chang, E. Ralfkiaer, C. Sundstrom, H. O. Adami, B. Glimelius and M. Melbye (2007) Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res. 67, 23822388.
  • 130
    Chang, E. T. and H. O. Adami (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 15, 17651777.
  • 131
    Dunleavey, R. (2005) The role of viruses and sexual transmission in anal cancer. Nurs. Times 101, 3841.
  • 132
    Gutierrez, J., A. Jimenez, J. De Dios Luna, M. J. Soto and A. Sorlozano (2006) Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus. J. Urol. 176(6 Pt 1), 24742481; discussion 2481.
  • 133
    Weinreb, D. B., G. T. Desman, M. J. Amolat-Apiado, D. E. Burstein, J. H. Godbold Jr and E. M. Johnson (2006) Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn. Cytopathol. 34, 201203.
  • 134
    Jimenez Pacheco, A., J. I. Martinez Torres, M. Pareja Vilchez, M. Arrabal Martin, F. Valle Diaz de la Guardia, V. Lopez Leon and A. Zuluaga Gomez (2007) Statistical analysis of the influence of the virus of papilloma human in the development of the vesical carcinoma. Actas Urol. Esp. 31, 469476.
  • 135
    Moonen, P. M., J. M. Bakkers, L. A. Kiemeney, J. A. Schalken, W. J. Melchers and J. A. Witjes (2007) Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur. Urol. 52, 464468.
  • 136
    Cougot, D., C. Neuveut and M. A. Buendia (2005) HBV-induced carcinogenesis. J. Clin. Virol. 34, S75S78.
  • 137
    Herrero, R., X. Castellsague, M. Pawlita, J. Lissowska, F. Kee, P. Balaram, T. Rajkumar, H. Sridhar, B. Rose, J. Pintos, L. Fernandez, A. Idris, M. J. Sanchez, A. Nieto, R. Talamini, A. Tavani, F. X. Bosch, U. Reidel, P. J. Snijders, C. J. Meijer, R. Viscidi, N. Munoz, S. Franceschi; I. A. R. C. Multicenter Oral Cancer Study Group (2003) Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J. Natl Cancer Inst. 95, 17721783.
  • 138
    Adami, H. O., H. Kuper, S. O. Andersson, R. Bergstrom and J. Dillner (2003) Prostate cancer risk and serologic evidence of human papilloma virus infection: A population-based case–control study. Cancer Epidemiol. Biomarkers Prev. 12, 872875.
  • 139
    Carozzi, F., F. C. Lombardi, P. Zendron, M. Confortini, C. Sani, S. Bisanzi, G. Pontenani and S. Ciatto (2004) Association of human papillomavirus with prostate cancer: Analysis of a consecutive series of prostate biopsies. Int. J. Biol. Markers 19, 257261.
  • 140
    Leiros, G. J., S. R. Galliano, M. E. Sember, T. Kahn, E. Schwarz and K. Eiguchi (2005) Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol. 5, 15.
  • 141
    Al-Maghrabi, J. A. (2007) The role of human papillomavirus infection in prostate cancer. Saudi Med. J. 28, 326333.
  • 142
    Schwartz, G. G. and B. S. Hulka (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res. 10, 13071311.
  • 143
    Devesa, S. S., D. J. Grauman, W. J. Blot, G. A. Pennello, R. N. Hoover and J. F. Fraumeni Jr. (1999) Atlas of Cancer Mortality in the United States, 1950–1994. NIH Publication No. 99-4564. Available at: Accessed on 29 September 2007.
  • 144
    Schwartz, G. G. (1992) Multiple sclerosis and prostate cancer: What do their similar geographies suggest? Neuroepidemiology 11, 244254.
  • 145
    Ault, K. A. (2006) Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect. Dis. Obstet. Gynecol. 2006(Suppl.), 40470.
  • 146
    Sugar, L. M. (2006) Inflammation and prostate cancer. Can. J. Urol. 13(Suppl. 1), 4647.
  • 147
    De Marzo, A. M., E. A. Platz, S. Sutcliffe, J. Xu, H. Gronberg, C. G. Drake, Y. Nakai, W. B. Isaacs and W. G. Nelson (2007) Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7, 256269.
  • 148
    Whitlatch, L. W., M. V. Young, G. G. Schwartz, J. N. Flanagan, K. L. Burnstein, B. L. Lokeshwar, E. S. Rich, M. F. Holick and T. C. Chen (2002) 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J. Steroid Biochem. Mol. Biol. 81, 135140.
  • 149
    Ma, J. F., L. Nonn, M. J. Campbell, M. Hewison, D. Feldman and D. M. Peehl (2004) Mechanisms of decreased vitamin D 1alpha-hydroxylase activity in prostate cancer cells. Mol. Cell. Endocrinol. 221, 6774.
  • 150
    Grant, W. B. (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94, 18671875.
  • 151
    Hostmark, J. G., O. D. Laerum and T. Farsund (1984) Seasonal variations of symptoms and occurrence of human bladder carcinomas. Scand. J. Urol. Nephrol. 18, 107111.
  • 152
    Chromek, M., Z. Slamova, P. Bergman, L. Kovacs, L. Podracka, I. Ehren, T. Hokfelt, G. H. Gudmundsson, R. L. Gallo, B. Agerberth and A. Brauner (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12, 636641.
  • 153
    Hao, Z., C. Koriyama, S. Akiba, J. Li, X. Luo, T. Itoh, Y. Eizuru and J. Zou (2002) The Epstein–Barr virus-associated gastric carcinoma in southern and northern China. Oncol. Rep. 9, 12931298.
  • 154
    Sleckman, B. G., P. M. Mauch, R. F. Ambinder, R. Mann, G. S. Pinkus, M. E. Kadin, B. Sherburne, A. Perez-Atayde, I. Thior and N. Mueller (1998) Epstein–Barr virus in Hodgkin’s disease: Correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol. Biomarkers Prev. 7, 11171121.
  • 155
    Chang, E. T., P. Blomqvist and M. Lambe (2005) Seasonal variation in the diagnosis of Hodgkin lymphoma in Sweden. Int. J. Cancer 115, 127130.
  • 156
    Porojnicu, A. C., T. E. Robsahm, A. H. Ree and J. Moan (2005) Season of diagnosis is a prognostic factor in Hodgkin’s lymphoma: A possible role of sun-induced vitamin D. Br. J. Cancer 93, 571574.
  • 157
    Spinelli, J. J., A. S. Lai, M. Krajden, A. Andonov, R. D. Gascoyne, J. M. Connors, A. R. Brooks-Wilson and R. P. Gallagher (2007) Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada. Int. J. Cancer 122, 630633.
  • 158
    Schwartz, G. G. and C. L. Hanchette (2006) UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States). Cancer Causes Control 17, 10911101.
  • 159
    Lagunova, Z., A. C. Porojnicu, A. Dahlback, J. P. Berg, T. M. Beer and J. Moan (2007) Prostate cancer survival is dependent on season of diagnosis. Prostate 67, 13621370.
  • 160
    Feldman, D., A. Krishnan, J. Moreno, S. Swami, D. M. Peehl and S. Srinivas (2007) Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancer. Nutr. Rev. 65, S113S115.
  • 161
    Algood, C. B., G. R. Newell and D. E. Johnson (1988) Viral etiology of testicular tumors. J. Urol. 139, 308310.
  • 162
    Akre, O., L. Lipworth, S. Tretli, A. Linde, L. Engstrand, H. O. Adami, M. Melbye, A. Andersen and A. Ekbom (1999) Epstein–Barr virus and cytomegalovirus in relation to testicular-cancer risk: A nested case–control study. Int. J. Cancer 82, 15.
  • 163
    Montella, M., L. Pezzullo, A. Crispo, F. Izzo, A. Amore, U. Marone, M. Tamburini, D. Ronga, M. G. Chiofalo, G. Chiappetta and N. Mozzillo (2003) Risk of thyroid cancer and high prevalence of hepatitis C virus. Oncol. Rep. 10, 133136.
  • 164
    Khadzkou, K., P. Buchwald, G. Westin, H. Dralle, G. Akerstrom and P. Hellman (2006) 25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma. J. Histochem. Cytochem. 54, 355361.
  • 165
    Chu, P. G., K. L. Chang, Y. Y. Chen, W. G. Chen and L. M. Weiss (2001) No significant association of Epstein–Barr virus infection with invasive breast carcinoma. Am. J. Pathol. 159, 571578.
  • 166
    Glaser, S. L., J. L. Hsu and M. L. Gulley (2004) Epstein–Barr virus and breast cancer: State of the evidence for viral carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 13, 688697.
  • 167
    Quirk, J. T., J. M. Kupinski and R. A. DiCioccio (2006) Analysis of ovarian tumors for the presence of human papillomavirus DNA. J. Obstet. Gynaecol. Res. 32, 202205.
  • 168
    Adani, G. L., U. Baccarani, D. Lorenzin, V. Bresadola, G. Curro, M. Sainz, M. Gropuzzo, D. Montanaro, P. Tulissi, A. Risaliti and F. Bresadola (2006) Role of cytomegalovirus and Epstein–Barr virus in patients with de novo colon cancer after renal transplantation. Tumori 92, 219221.
  • 169
    Weber, G., J. D. Heilborn, C. I. Chamorro Jimenez, A. Hammarsjo, H. Torma and M. Stahle (2005) Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Invest. Dermatol. 124, 10801082.
  • 170
    Yim, S., P. Dhawan, C. Ragunath, S. Christakos and G. Diamond (2007) Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros. 6, 403410.
  • 171
    Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, D. L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zugel, R. L. Gallo, D. Eisenberg, M. Hewison, B. W. Hollis, J. S. Adams, B. R. Bloom and R. L. Modlin (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 17701773.
  • 172
    Harris, S. S. (2006) Vitamin D and African Americans. J. Nutr. 136, 11261129.
  • 173
    Adams, J. S., P. Liu, R. Chun, R. L. Modlin and M. Hewison (2007) Vitamin D in defense of the human immune response. Ann. N. Y. Acad. Sci. (Epub ahead of print).
  • 174
    Herr, C., R. Shaykhiev and R. Bals (2007) The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin. Biol. Ther. 7, 14491461.
  • 175
    Gordon, Y. J., L. C. Huang, E. G. Romanowski, K. A. Yates, R. J. Proske and A. M. McDermott (2005) Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr. Eye Res. 30, 385394.
  • 176
    Grant, W. B. (2007) Roles of solar ultraviolet radiation and vitamin D in human health and how to obtain vitamin D. Expert Rev. Dermatol. 2, 563577.
  • 177
    Whiting, S. J. and M. S. Calvo (2005) Dietary recommendations to meet both endocrine and autocrine needs of vitamin D. J. Steroid Biochem. Mol. Biol. 97, 712.
  • 178
    Vieth, R., H. Bischoff-Ferrari, B. J. Boucher, B. Dawson-Hughes, C. F. Garland, R. P. Heaney, M. F. Holick, B. W. Hollis, C. Lamberg-Allardt, J. J. McGrath, A. W. Norman, R. Scragg, S. J. Whiting, W. C. Willett and A. Zittermann (2007) The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 85, 649650.